Glycan Oxazoline—a core tool for glycoprotein engineering research 1072107-93-7

Glycan Oxazoline (glycosyl oxazoline) is a key molecule in the field of glycoscience and biopharmaceuticals. With its unique structure and reactivity, it plays an indispensable role in glycosylation engineering, glycobiology research and therapeutic protein development. As an efficient intermediate for the chemical-enzymatic synthesis of glycoconjugates, it provides strong support for achieving uniform and specific glycosylation modifications and is driving the progress of the next generation of biotherapeutics and diagnostic tools.

Chemical Information

Chemical name: Glycan Oxazoline derivative (No. CBNGO00034)

Common name: Glycosyloxazoline

Chemical formula: C32H53NO25

Molecular weight: 851.76 g/mol

CAS number: 1072107-93-7

Structural features

The structure of Glycan Oxazoline is based on the glycosyl oxazoline ring system. Its design cleverly combines the diversity of sugar chains with the high reactivity of the oxazoline ring. Its main features include:

Oxazoline ring core: The center of the molecule is a five-membered oxazoline heterocyclic ring, formed by the condensation of the sugar reducing end and the nitrogen-containing component. The ring contains nitrogen atoms and oxygen atoms, and its electron distribution and rigid conformation simulate the transition state of the glycosidic bond, making it an ideal glycosyl donor in enzymatic reactions.

Stable sugar chain carrier: The chemical formula C32H53NO25 corresponds to a multi-branched complex sugar chain structure, usually composed of glucose, mannose and other monosaccharide units, and can accurately simulate high-mannose or complex sugar chains in natural glycoproteins. This design retains the biological recognition function of the sugar chain while enhancing chemical stability through the oxazoline ring to avoid non-specific hydrolysis during storage or reaction.

Flexible connection and compatibility: The connection bond between the oxazoline ring and the sugar chain is moderately flexible, allowing the sugar chain to be directionally arranged in the enzyme active pocket, and is compatible with a variety of glycosyltransferases or endoglycosidases, making it suitable for a wide range of biocatalytic scenarios. In addition, the structure can be chemically modified to adjust the sugar chain length or substituents to meet specific research or application needs.

Main applications and advantages

Core tools for glycoprotein synthesis and engineering

In the field of biopharmaceuticals, glycosylation modification of proteins directly affects their stability, half-life, immunogenicity and biological activity. Traditional chemical synthesis of glycoproteins faces the problems of tedious steps and low yields, while Glycan Oxazoline provides an efficient solution through enzymatic glycosylation. As a glycosyl donor, it can undergo a transfer reaction with specific glycosylation sites on proteins or peptide chains under the catalysis of endoglycosidase (such as Endo-A or Endo-M) to achieve site-specific and uniform glycoprotein modification. This method has been widely used to produce monoclonal antibodies, enzyme replacement therapy proteins and virus-like particle vaccines, significantly improving the efficacy and safety of therapeutic proteins. For example, in cancer immunotherapy, uniformly glycosylated antibodies prepared with Glycan Oxazoline enhance antibody-dependent cellular toxicity while reducing the risk of inflammation.

Probe molecules for studying glycobiological mechanisms

Glycosylation is one of the most complex post-translational modifications in eukaryotic cells, involved in processes such as intercellular communication, pathogen recognition, and disease development. Glycan Oxazoline provides a key tool for deciphering these mechanisms: its stable oxazoline ring allows the reconstruction of glycosyltransferase reactions in vitro for enzyme kinetic studies, inhibitor screening and structure-function relationship analysis; at the same time, labeled Glycan Oxazoline derivatives can be used as fluorescent or biotin probes to track the metabolic pathways of sugar chains in cells or locate the distribution of glycoproteins in tissues. These applications help reveal the role of glycosylation in cancer, neurodegenerative diseases, or infectious diseases, laying the foundation for drug development targeting glycopathways.

Antigen module for diagnostics and vaccine development

Many diseases are accompanied by abnormal expression of specific sugar chain structures, such as tumor-associated sugar antigens (such as Tn antigen or Globo family of glycolipids), and these sugar epitopes can serve as diagnostic biomarkers or vaccine targets. Glycan Oxazoline can efficiently synthesize these complex carbohydrate antigens and enzymatically couple them to carrier proteins or peptides to prepare uniform glycoconjugates. Such conjugates are used to develop highly sensitive diagnostic reagents (such as ELISA or microarray assays) or as vaccine immunogens to induce specific immune responses. In the field of infectious diseases, glycomimetics based on Glycan Oxazoline can simulate the sugar-coated structure on the surface of pathogens and are used to develop antiviral or antibacterial vaccines, with the potential advantages of low immunogenicity and high safety.

Universal building blocks for chemoenzymatic synthesis platforms

With the development of synthetic biology, chemoenzymatic methods have become the mainstream strategy for constructing complex glycoconjugates. Glycan Oxazoline serves as a universal building block, with its oxazoline ring selectively activated under mild conditions and linked to a variety of receptors (such as peptides, lipids or other sugar chains) through a one-pot enzymatic reaction to efficiently generate glycopeptides, glycolipids or polysaccharide arrays. This method overcomes the limitations of protecting group operations in traditional chemical synthesis, greatly shortens the synthesis cycle and improves yield, and provides a modular tool for carbohydrate drug discovery (such as glycosylation inhibitors or aptamers) and cell surface engineering.

Conclusion

Glycan Oxazoline is not only a chemical molecule, but also a bridge connecting basic research in glycoscience and clinical application. From optimizing glycosylation quality control of biopharmaceuticals, to decoding disease-related glycocodes, to innovative vaccine design, its multifaceted capabilities continue to expand the boundaries of glycobiology. With the advancement of precision medicine and synthetic biology, the tool value of Glycan Oxazoline will become increasingly prominent, helping to develop safer and more efficient next-generation therapies and diagnostic solutions, bringing far-reaching impact to human health.

The above information is provided by the editor of KASONS and is for scientific research only.